YUANSHANGFANG (HONG KONG) TECHNOLOGY LIMITED – Trademark Portfolio

Entity Type: 16

YUANSHANGFANG (HONG KONG) TECHNOLOGY LIMITED holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include BVVJJ. The owner is based in KOWLOON.

RM.517, NEW CITY CENTRE, 2 LEI YUE MUN ROAD, KWUN TONG

KOWLOON 999077 , HK

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BVVJJ
BVVJJ
Registered 2024

Trademark Classifications

YUANSHANGFANG (HONG KONG) TECHNOLOGY LIMITED's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does YUANSHANGFANG (HONG KONG) TECHNOLOGY LIMITED have?

YUANSHANGFANG (HONG KONG) TECHNOLOGY LIMITED has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does YUANSHANGFANG (HONG KONG) TECHNOLOGY LIMITED file in?

YUANSHANGFANG (HONG KONG) TECHNOLOGY LIMITED files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are YUANSHANGFANG (HONG KONG) TECHNOLOGY LIMITED's most well-known trademarks?

YUANSHANGFANG (HONG KONG) TECHNOLOGY LIMITED's registered trademark portfolio includes well-known marks such as BVVJJ. These are among 1 currently registered trademark in the portfolio.

What is YUANSHANGFANG (HONG KONG) TECHNOLOGY LIMITED's trademark registration success rate?

YUANSHANGFANG (HONG KONG) TECHNOLOGY LIMITED has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.